Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
If you: Have contraindications or complex medical needs requiring in-person care Strongly prefer FDA-approved medications and can access them affordably Want comprehensive support beyond medication (nutrition counseling, behavioral therapy, etc.) Are uncomfortable with the regulatory uncertainty around compounded GLP-1s Cannot commit to long-term treatment costs and requirements Then other pathways - in-person obesity medicine, bariatric surgery evaluation, or continued lifestyle-based approaches with professional support - may serve you better
Scientific References Creating the amylin story
1 However, if you also take sulfonylureas or insulin, your risk is higher
BMJ 374:n1648 Cysique LA, Jakabek D, Bracken SG, Allen-Davidian Y, Heng B, Chow S, Dehhaghi M, Pires AS, Darley DR, Byrne A, Phetsouphanh C, Kelleher A, Dore GJ, Matthews GV, Guillemin GJ, Brew BJ (2022) Post-acute Covid-19 cognitive impairment and decline uniquely associate with kynurenine pathway activation: a longitudinal observational study
